Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma. N Engl J Med. 2022 02 17; 386(7):640-654.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological
Biological Products
Drug Resistance, Neoplasm
Female
Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse
Male
Middle Aged
Stem Cell Transplantation
Transplantation, Autologous
authors with profiles
Peter Riedell